// App-Quantinova.ai

e15545 : FDG-PET/CT in the prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the esophagus and esophagogastric junction.

Researchers

Presenter

  • Tomas Harustiak

Principal Investigators

  • Pavel Fencl

  • Ludmila Hornofova

  • Alexandr Pazdro

  • Martin Snajdauf

  • Zdenka Pechacova

  • Lubos B. Petruzelka

  • Milada Zemanova

Medical Centers

  • 3rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

  • Department of Nuclear Medicine and PET Center, Na Homolce Hospital, Prague, Czech Republic

  • Department of Patology and Molecular Medicine, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic

  • Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

  • Department of Oncology, First Faculty of Medicine, Charles University in Prague, Husinec-Rez, Czech Republic

  • Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • Total lesion glycolysis

Drug/Treatment

  • Adrucil injection

  • Capecitabine

  • Epirubicin

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved